Sage Journals: Discover world-class research

Retricted access

Research article

First published 2015-7

Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban

Robert C. Gosselin, Suzanne J. Francart, Emily M. Hawes [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2022-12

Evaluation of Anti-Xa Apixaban and Rivaroxaban Levels With Respect to Known Doses in Relation to Major Bleeding Events

Steffany N. Nguyen, Melanie C. Ruegger, Eric Salazar [...]

Journal of Pharmacy Practice

Open access

Research article

First published 2024

Anti-Xa Activity Monitoring for Optimizing Rivaroxaban Dosage in Chinese Patients with Cerebral Venous Thrombosis

Xiaoming Zhang, Meini Gao, Duo Lan [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2018-3

Comparison of Anti-Xa Activity in Patients Receiving Apixaban or Rivaroxaban

David A. Bookstaver, Kimberly Sparks, Brandon S. Pybus [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2025

Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients

Kaitlin Blotske, Toral Patel, Toby Trujillo [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2019-4

Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator

Paul Billoir, Virginie Barbay, Luc Marie Joly [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2021

Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury

William Towers, Steffany N. Nguyen, Melanie C. Ruegger [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2026-2

A Single Health System Retrospective Qualitative Analysis of Inpatient Apixaban and Rivaroxaban Calibrated Anti-Xa Level Monitoring and Clinical Implications

Bailey McCarville, Jennifer Osborn

Hospital Pharmacy

Retricted access

Review article

First published 2019-6

Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban

Irene Abuan, Kristine H. Wong, Benjamin Bolinske [...]

Journal of Pharmacy Technology

Free access

Research article

First published 2024-1

Comparison of the Correlation Between Coagulation Indices and Rivaroxaban Concentrations

Tingting Wu, Shuyi Wu, Meijuan Li [...]

Annals of Pharmacotherapy

Search results